Cargando…
Long use of continuous positive airway pressure protects against the development of treatment-requiring retinopathy of prematurity
Although preterm infant mortality is low, the proportion of patients with treatment-requiring retinopathy of prematurity (TR-ROP) is high in Japan. Various multicenter studies have reported the risk factors for TR-ROP; however, no large-scale studies have been conducted in Japan. We retrospectively...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098540/ https://www.ncbi.nlm.nih.gov/pubmed/35551213 http://dx.doi.org/10.1038/s41598-022-11509-w |
_version_ | 1784706407269924864 |
---|---|
author | Suga, Shutaro Kyono, Yuki Kido, Takumi Nakasone, Ruka Abe, Shinya Ashina, Mariko Nozu, Kandai Fujioka, Kazumichi |
author_facet | Suga, Shutaro Kyono, Yuki Kido, Takumi Nakasone, Ruka Abe, Shinya Ashina, Mariko Nozu, Kandai Fujioka, Kazumichi |
author_sort | Suga, Shutaro |
collection | PubMed |
description | Although preterm infant mortality is low, the proportion of patients with treatment-requiring retinopathy of prematurity (TR-ROP) is high in Japan. Various multicenter studies have reported the risk factors for TR-ROP; however, no large-scale studies have been conducted in Japan. We retrospectively analyzed 13,645 infants born at < 28 weeks’ gestation (January 1, 2009–December 31, 2018), and registered in the Neonatal Research Network of Japan database. TR-ROP was defined as ROP requiring retinal laser photocoagulation and/or intravitreal anti-vasoendothelial growth factor drugs. Multivariable logistic regression analysis was performed to identify factors associated with TR-ROP development. The median gestational age of enrolled infants was 26 weeks (interquartile range [IQR], 24–27 weeks), median birth weight was 760 g (IQR, 620–918 g). Proportion of patients with TR-ROP was 30.3%. TR-ROP was significantly associated with birth at < 26 weeks’ gestational age (adjusted odds ratio [aOR] 1.54), blood transfusion (aOR 1.49), invasive ventilation ≥ 28 days (aOR 1.41), sepsis (aOR 1.29), birth weight < 750 g (aOR 1.28), intraventricular hemorrhage (aOR 1.33), delayed achievement of full enteral feeding > 14 days (aOR 1.28), and continuous positive airway pressure (CPAP) therapy ≥ 28 days (aOR 0.79). Supplemental oxygen ≥ 28 days was not associated with TR-ROP development. Lower gestational age at birth and birth weight, blood transfusion, prolonged invasive ventilation, sepsis, intraventricular hemorrhage, and delayed achievement of full enteral feeding were risk factors for TR-ROP, whereas CPAP use was protective against TR-ROP. |
format | Online Article Text |
id | pubmed-9098540 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-90985402022-05-14 Long use of continuous positive airway pressure protects against the development of treatment-requiring retinopathy of prematurity Suga, Shutaro Kyono, Yuki Kido, Takumi Nakasone, Ruka Abe, Shinya Ashina, Mariko Nozu, Kandai Fujioka, Kazumichi Sci Rep Article Although preterm infant mortality is low, the proportion of patients with treatment-requiring retinopathy of prematurity (TR-ROP) is high in Japan. Various multicenter studies have reported the risk factors for TR-ROP; however, no large-scale studies have been conducted in Japan. We retrospectively analyzed 13,645 infants born at < 28 weeks’ gestation (January 1, 2009–December 31, 2018), and registered in the Neonatal Research Network of Japan database. TR-ROP was defined as ROP requiring retinal laser photocoagulation and/or intravitreal anti-vasoendothelial growth factor drugs. Multivariable logistic regression analysis was performed to identify factors associated with TR-ROP development. The median gestational age of enrolled infants was 26 weeks (interquartile range [IQR], 24–27 weeks), median birth weight was 760 g (IQR, 620–918 g). Proportion of patients with TR-ROP was 30.3%. TR-ROP was significantly associated with birth at < 26 weeks’ gestational age (adjusted odds ratio [aOR] 1.54), blood transfusion (aOR 1.49), invasive ventilation ≥ 28 days (aOR 1.41), sepsis (aOR 1.29), birth weight < 750 g (aOR 1.28), intraventricular hemorrhage (aOR 1.33), delayed achievement of full enteral feeding > 14 days (aOR 1.28), and continuous positive airway pressure (CPAP) therapy ≥ 28 days (aOR 0.79). Supplemental oxygen ≥ 28 days was not associated with TR-ROP development. Lower gestational age at birth and birth weight, blood transfusion, prolonged invasive ventilation, sepsis, intraventricular hemorrhage, and delayed achievement of full enteral feeding were risk factors for TR-ROP, whereas CPAP use was protective against TR-ROP. Nature Publishing Group UK 2022-05-12 /pmc/articles/PMC9098540/ /pubmed/35551213 http://dx.doi.org/10.1038/s41598-022-11509-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Suga, Shutaro Kyono, Yuki Kido, Takumi Nakasone, Ruka Abe, Shinya Ashina, Mariko Nozu, Kandai Fujioka, Kazumichi Long use of continuous positive airway pressure protects against the development of treatment-requiring retinopathy of prematurity |
title | Long use of continuous positive airway pressure protects against the development of treatment-requiring retinopathy of prematurity |
title_full | Long use of continuous positive airway pressure protects against the development of treatment-requiring retinopathy of prematurity |
title_fullStr | Long use of continuous positive airway pressure protects against the development of treatment-requiring retinopathy of prematurity |
title_full_unstemmed | Long use of continuous positive airway pressure protects against the development of treatment-requiring retinopathy of prematurity |
title_short | Long use of continuous positive airway pressure protects against the development of treatment-requiring retinopathy of prematurity |
title_sort | long use of continuous positive airway pressure protects against the development of treatment-requiring retinopathy of prematurity |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098540/ https://www.ncbi.nlm.nih.gov/pubmed/35551213 http://dx.doi.org/10.1038/s41598-022-11509-w |
work_keys_str_mv | AT sugashutaro longuseofcontinuouspositiveairwaypressureprotectsagainstthedevelopmentoftreatmentrequiringretinopathyofprematurity AT kyonoyuki longuseofcontinuouspositiveairwaypressureprotectsagainstthedevelopmentoftreatmentrequiringretinopathyofprematurity AT kidotakumi longuseofcontinuouspositiveairwaypressureprotectsagainstthedevelopmentoftreatmentrequiringretinopathyofprematurity AT nakasoneruka longuseofcontinuouspositiveairwaypressureprotectsagainstthedevelopmentoftreatmentrequiringretinopathyofprematurity AT abeshinya longuseofcontinuouspositiveairwaypressureprotectsagainstthedevelopmentoftreatmentrequiringretinopathyofprematurity AT ashinamariko longuseofcontinuouspositiveairwaypressureprotectsagainstthedevelopmentoftreatmentrequiringretinopathyofprematurity AT nozukandai longuseofcontinuouspositiveairwaypressureprotectsagainstthedevelopmentoftreatmentrequiringretinopathyofprematurity AT fujiokakazumichi longuseofcontinuouspositiveairwaypressureprotectsagainstthedevelopmentoftreatmentrequiringretinopathyofprematurity |